Nixar 20 mg tablete
| Name | Nixar 20 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-535007756 |
| Active Substance | bilastin |
| Composition | jedna tableta sadrži 20 mg bilastina |
| Pharmaceutical Form | tableta |
| Manufacturer | Faes Farma S.A., Leioa (Vizcaya), Španjolska
A. Menarini Manufacturing Logistics And Services S.r.l., L'Aquila, Italija Menarini-Von Heyden GmbH, Dresden, Njemačka |
| Marketing Authorisation Holder | Menarini International Operations Luxembourg S.A., 1, Avenue de la Gare, Luksemburg, Luksemburg |
| Marketing Authorisation Date | 12.01.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/515 |
| Registration Number | 381-12-01/30-18-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R06AX29 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Summary of risk management plan | download |
